Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD



Rating:

Share or cite this content

Citations should be made in the following way:
R. Gregg (Pittsburgh, United States of America), P. Benos (Pittsburgh, United States of America). Leveraging causal modeling to predict future COPD. 3831

Member's Comments

No comment yet.

Related content which might interest you: Evaluating COPD disease management: application of a theoretical model Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Is it possible to predict asthma outcomes? A disease model for economic analysis. Source: International Congress 2017 – Asthma management Year: 2017 A general framework to implement predictive models for hospitalizations: Application to COPD Source: International Congress 2017 – Best abstracts in the management of chronic respiratory diseases Year: 2017 A new model to understand the concept physical activity for patients with COPD Source: Annual Congress 2011 - Physical activity, methodology and impact Year: 2011 Clinical clustering of COPD patients is useful to predict future COPD exacerbations Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Genome-based risk prediction of asthma and COPD: applicability and psychological issues Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine Year: 2012 Comparison of multidimensional assessment systems with regard to risk prediction for exacerbations of COPD Source: Annual Congress 2011 - COPD exacerbation Year: 2011 How to define asthma in large-scale studies? Source: International Congress 2014 – Is asthma prevalence still increasing? Year: 2014 The need and potential of patient-specific modelling Source: Annual Congress 2012 - PG13 AirPROM: patient-specific modelling and systems biology living labs workshop Year: 2012 Identifying tools to investigate outcomes following an exacerbation of COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Is poor asthma self-management due to failure to recognise symptoms or failure to act? Novel insights from mining large-scale clinical observational study Source: International Congress 2019 – M-health/e-health II Year: 2019 Features of asthma management: quantifying the patient‘s perspective using discrete choice modelling Source: Eur Respir J 2006; 28: Suppl. 50, 122s Year: 2006 Mathematical model to predict the risk of future exacerbations in non-smoking patients with COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Using population insight studies to define effective prevention and identification interventions in COPD Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care Year: 2011 Modelling and simulation in successful drug development programmes: Characterisation of exacerbation reduction with roflumilast to corroborate the importance of defining patient subsets in COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Population segmentation to identify priority targets for identification and behaviour change interventions in COPD Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011 Revising our approach to conducting therapeutic clinical research in COPD Source: Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017 Year: 2018